Minimal Clinically Important Difference of the Box and Block Test in Parkinson

NCT ID: NCT06490809

Last Updated: 2025-03-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-01

Study Completion Date

2025-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to examine the level of clinical change in gross manual skills of Parkinson's patients who receive conventional physiotherapy. For this purpose, the Box-Block Test will be used, and the amount of change that must occur in the patient's hand functions will be determined for the test to be considered clinically meaningful.

Patients will continue their routine physical therapy sessions and the researchers will not interfere with this program. The treatment program will be created by the clinical specialist physician and physiotherapist.

Upper extremity rehabilitation programs for Parkinson's patients generally consist of methods such as stretching, strengthening, reaching, coordination and recreational activities. Patients will receive physiotherapy for 30 sessions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

An independent Researcher will perform a statistical analysis.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Routine Physiotherapy Group

No action will be taken by the researchers on this group's treatment program.

Group Type EXPERIMENTAL

Physiotherapy

Intervention Type OTHER

Parkinson\'s upper extremity rehabilitation generally consists of stretching, strengthening, coordination, recreational activities and skill activities. Exercises will be prescribed by the clinical specialist physician and physiotherapist.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physiotherapy

Parkinson\'s upper extremity rehabilitation generally consists of stretching, strengthening, coordination, recreational activities and skill activities. Exercises will be prescribed by the clinical specialist physician and physiotherapist.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Being Hoehn \& Yahr Stage between 1-3,
* Individuals in the "On" phase,
* Those who were not exposed to any physiotherapy intervention during the initial assessment

Exclusion Criteria

* Mini-mental status assessment \< 24 points;
* Presence of severe dyskinesia,
* Those who experience fluctuations in the on-off phase,
* Those who have undergone stereotaxic brain surgery for Parkinson's,
* Individuals with changes in dopamine dose within three months,
* Presence of unstable cardiac and respiratory disease
* Those with an orthopedic problem or a history of surgery affecting upper extremity performance.
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Emre Şenocak

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emre Şenocak

Research Assisstant

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Murat Emirzeoğlu, PhD

Role: STUDY_CHAIR

Karadeniz Technical University

Tuğba Eyigürbüz, PhD

Role: STUDY_CHAIR

Bağcılar Education and Research Hospital

Adem Aktürk, PhD

Role: STUDY_CHAIR

İstanbul Gelişim University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Özel Öz İstanbul Tıp Merkezi

Istanbul, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Emre Şenocak, PhD

Role: CONTACT

+90 553 569 56 92

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Adem Aktürk, PhD

Role: primary

+90 533 310 23 15

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

E-13562490-050.01.04-51

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.